Tumor-infiltrating CD8+ T cells and CD68+ TAMs in resected gastric cancer are predictive of the postoperative prognosis and benefits of adjuvant chemotherapy (7), whereas FOXP3+ T-cell infiltration is associated with worse outcomes (25). This evidence concerns the gene CD68 and neoplasm.